Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Feb 2026, Mar 2026, May 2026, Aug 2026 and Sep 2026.
- Largest single sale: $489K (19,379 shares) of Arcutis Biotherapeutics, Inc. on Feb 2, 2026. Filing
- Last sale before this period: Sep 4, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Reporting Person's title: EVP, Chief Legal Officer | Jan 5, 2022 | Sep 18, 2026 |
| Halozyme Therapeutics, Inc. (HALO) | Former SVP, General Counsel | Jan 6, 2020 | Sep 7, 2021 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 16, 2026, Arcutis Biotherapeutics, Inc.: sold 3,674 shares for $92K, under a disclosed plan. 1 filing: 1
- Sep 8, 2026, Arcutis Biotherapeutics, Inc.: sold 9,989 shares for $250K, under a disclosed plan. 1 filing: 1
- Aug 3, 2026, Arcutis Biotherapeutics, Inc.: sold 1,230 shares for $32K, under a disclosed plan. 1 filing: 1
- May 4, 2026, Arcutis Biotherapeutics, Inc.: sold 8,256 shares for $192K, under a disclosed plan. 1 filing: 1
- Mar 2, 2026, Arcutis Biotherapeutics, Inc.: sold 8,733 shares for $221K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.